Update on diagnostic and therapeutic strategies for antibody-mediated rejection in kidney transplantation

doi:10.5500/wjt.v16.i1.111524

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

(41)

(0)

(18)

(2359)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Mar 18, 2026; 16(1): 111524
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.111524

Full Size Figure Download Figure

Figure 2 Mechanism of antibody-mediated rejection. (Source: Biorender.com). NK cells: Natural killer cells; IFN: Interferon; TNF: Tumour necrosis factor; HLA: Human leukocyte antigen.

Citation: Elahi T, Ahmed S, Mubarak M. Update on diagnostic and therapeutic strategies for antibody-mediated rejection in kidney transplantation. World J Transplant 2026; 16(1): 111524
URL: https://www.wjgnet.com/2220-3230/full/v16/i1/111524.htm
DOI: https://dx.doi.org/10.5500/wjt.v16.i1.111524

Elahi T, Ahmed S, Mubarak M. Update on diagnostic and therapeutic strategies for antibody-mediated rejection in kidney transplantation. World J Transplant 2026; 16(1): 111524 [PMID: 41607817 DOI: 10.5500/wjt.v16.i1.111524]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.